Therefore, this study aimed to explore the possibility of testis-specific lncRNA RFPL3S as a biomarker for TGCT diagnosis, prognosis, and treatment response by reviewing the TGCT gene expression data in Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Here, RFPL3S is linked to testicular germ cell tumor.